Form 10-Q · Quarterly report
Brown & Brown 10-Q, filed Oct 26, 2026
- Filed
- CIK
- 0000079282
- Accession no.
- 0001193125-26-432146
Summary
Brown & Brown reported third-quarter 2026 total commissions and fees growth of 9.7%, with organic revenue up 1.2% and organic revenue including contingents up 1.5%. Income before income taxes rose $9 million, or 2.9%, from the third quarter of 2025, helped by higher contingents, expense leverage, the acquisition of Accession and acquisitions completed over the prior twelve months, partly offset by a change in estimated acquisition earn-out payables.
Key points
- Total commissions and fees grew 9.7% for the three months ended September 30, 2026.
- Consolidated organic revenue rose 1.2%, and organic revenue with contingents rose 1.5%.
- Income before income taxes increased $9 million, or 2.9%, versus the third quarter of 2025.
- Contingent commissions have averaged about 4.4% of total commissions and fee revenues over the last three years.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations The following discussion updates the Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and the two discussions should be read together. GENERAL Company Overview — Third Quarter of 2026 The following discussion should be read in conjunction with our Condensed Consolidated Financial Statements and the related Notes to those Financial Statements included elsewhere in this Quarterly Report on Form 10-Q, which are prepared in accordance with accounting principles…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.